Intrafer

Iron sucrose, the active ingredient in Intrafer, is an iron preparation presented as an intravenous solution for intravenous use. It treats iron deficiency anemia and is used in patients with chronic kidney disease to replenish iron stores and support hemoglobin synthesis.

GNH USA supplies Intrafer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Intrafer (iron sucrose) is employed to manage conditions related to iron deficiency and anemia.

- Iron deficiency anemia: restores hemoglobin levels and replenishes depleted iron stores. - Anemia associated with chronic kidney disease: provides elemental iron for hemoglobin synthesis in patients receiving dialysis or other CKD therapies.

Common Side Effects: - Nausea: mild to moderate discomfort in the stomach. - Headache: transient pain often occurring during or after infusion. - Muscle cramps: involuntary tightening of muscles, usually in the limbs. - Injection site pain: local discomfort at the site of administration. - Flushing: temporary reddening and warmth of the skin. - Hypertension: temporary rise in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: severe, potentially life‑threatening allergic response. - Hypotension: sudden drop in blood pressure requiring monitoring. - Acute respiratory distress: difficulty breathing that may develop rapidly. - Iron overload: excessive iron accumulation leading to organ damage. - Arrhythmia: irregular heart rhythm that may require medical attention.

Before using Intrafer, consider the following precautions: - Renal impairment: monitor iron parameters and renal function closely. - Cardiovascular disease: observe blood pressure during and after infusion. - History of hypersensitivity: avoid if the patient has previously reacted to iron sucrose. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Concurrent erythropoiesis‑stimulating agents: adjust dosing to prevent excessive hemoglobin rise. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intrafer may interact with other medications as follows.

Major Interactions (Avoid): - Concurrent parenteral iron products: increase risk of iron overload. - High‑dose vitamin C infusion: may enhance free iron release and toxicity. - Iron chelating agents (e.g., deferoxamine): bind administered iron and reduce efficacy.

Moderate Interactions (Monitor Closely): - Erythropoiesis‑stimulating agents: may potentiate hemoglobin increase, requiring dose adjustment. - Antihypertensive drugs: monitor blood pressure due to possible infusion‑related hypertension. - Oral phosphate binders: may interfere with laboratory assessment of iron parameters.